StoneX Group’s Core Laboratories CLB Stock Holding History

StoneX Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,205	Closed	-$223K	–	206
2017 Q2	$223K	Buy	+2,205	New	+$238K	0.07%	343

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

StoneX Group's CLB Position: Q3 2017 in Review

StoneX Group sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 2,205 shares — an estimated $223K sold.

StoneX Group first reported a position in CLB in Q2 2017 and held it in 1 quarter. The position peaked at $223K in Q2 2017. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

StoneX Group reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
StoneX Group sold 2,205 Core Laboratories shares in Q3 2017, an estimated $223K.
StoneX Group first reported a position in Core Laboratories in Q2 2017 and held it in 1 quarter.
StoneX Group's Core Laboratories position peaked at $223K in Q2 2017.
345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on StoneX Group's 13F filing for Q3 2017, filed 13 Nov 2017.